You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Heparin, Low-Molecular-Weight

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Venous Thromboembolism Trial in Toronto (Prophylactic low molecular weight heparin, Low molecular weight heparin and low-dose

Recruiting
  • Venous Thromboembolism
  • Prophylactic low molecular weight heparin
  • Low molecular weight heparin and low-dose aspirin
  • Toronto, Ontario, Canada
    Mount Sinai Hospital
Jan 18, 2023

Thromboembolism Trial in Salt Lake City (Enoxaparin)

Recruiting
  • Thromboembolism
  • Salt Lake City, Utah
    University of Utah
Nov 6, 2023

BMD and Ca-P Metabolism in RSA Patients: LMWH Use Versus Control

Recruiting
  • Recurrent Spontaneous Abortion
  • Low molecular weight heparin
  • Shanghai, Shanghai, China
    Renji Hospital, Shanghai Jiaotong University School of Medicine
May 18, 2023

Stroke Trial in Kastamonu (The Effect of Different Pressure Periods on Bruising and Pain After Subcutaneous Heparin Injection

Completed
  • Stroke
  • The Effect of Different Pressure Periods on Bruising and Pain After Subcutaneous Heparin Injection Applied to the Upper Arm Region
  • Kastamonu, Turkey
    Kastamonu University
Oct 6, 2023

Compare Health Care Costs Between Apixaban and Low Molecular

Active, not recruiting
  • Thromboembolism
    • New York, New York
      Pfizer Investigational
    Dec 1, 2022

    Dose Regimen of Intravenous Unfractionated Heparin and Low

    Active, not recruiting
    • COVID-19
    • +3 more
    • Gent, Belgium
      Ghent University Hospital
    Oct 24, 2022

    Sarcoma, Soft Tissue Sarcoma, Bone Sarcoma Trial in Boston (Aspirin 325mg, Enoxaparin 40Mg/0.4mL Prefilled Syringe)

    Enrolling by invitation
    • Sarcoma
    • +6 more
    • Aspirin 325mg
    • Enoxaparin 40Mg/0.4mL Prefilled Syringe
    • Boston, Massachusetts
      Santiago Lozano-Calderon
    Jan 20, 2023

    Injection Site Bruising, Bruising, Pain Trial (Cold application)

    Completed
    • Injection Site Bruising
    • +2 more
    • Cold application
    • (no location specified)
    Mar 4, 2023

    Venous Thromboembolism Trial (Peak value anti-Xa, Trough value anti-Xa, Control Group)

    Not yet recruiting
    • Venous Thromboembolism
    • Peak value anti-Xa
    • +2 more
    • (no location specified)
    May 15, 2022

    Sildenafil Citrate Added to Low Molecular Weight Heparin and Low

    Withdrawn
    • High Risk Pregnancy
    • Fayoum, Egypt
      sahar M.Y elbaradie
    Mar 17, 2022

    Atrial Fibrillation in Patients With Cancer (MAFIC Study)

    Recruiting
    • Cancer
    • Atrial Fibrillation
    • Low molecular weight heparin
    • Thessaloniki, Greece
    • +1 more
    Feb 14, 2022

    Sterility Trial in Beirut (Bemiparin sodium)

    Recruiting
    • Sterility
    • Bemiparin sodium
    • Beirut, Lebanon
      American University of Beirut Medical Center
    Feb 21, 2022

    Thromboembolism, Postpartum DVT, Thrombosis Trial in Salt Lake City (Enoxaparin)

    Completed
    • Thromboembolism
    • +2 more
    • Salt Lake City, Utah
      University of Utah
    Jan 26, 2022

    Venous Thrombosis, Tumors Trial in Minneapolis, Columbus, Milwaukee (Heparin, Low-Molecular-Weight, or direct oral

    Completed
    Has Results
    • Venous Thrombosis
    • Neoplasms
    • Heparin, Low-Molecular-Weight, or direct oral anticoagulants
    • Minneapolis, Minnesota
    • +2 more
    Apr 26, 2022

    Rivaroxaban Versus Low-molecular-weight Heparin and

    Completed
    • Venous Thromboembolism
    • Rivaroxaban (Xarelto, BAY 59-7939)
    • LMWH and Phenprocoumon
    • Multiple Locations, Germany
      Multiple facilities
    Apr 27, 2022

    Is Anti-Factor Xa Associated With Outcome in Critical COVID-19

    Completed
    • Covid19
    • +2 more
    • The effect of LMWH
    • Monitoring frequency of aFXa-levels
    • Stockholm, Sweden
      Södersjukhuset
    Feb 24, 2022

    Reduced Dose Thrombolytic in Intermediate/High Risk Pulmonary

    Recruiting
    • Pulmonary Embolism
    • Tissue Plasminogen Activator, Alteplase
    • Low-molecular weight heparin
    • İzmir, Bornova/İzmir, Turkey
      Ege University
    Aug 22, 2022

    Venous Thromboembolism Trial in Moscow (drug, device, diagnostic test)

    Recruiting
    • Venous Thromboembolism
    • Standard Enoxaparin 40 mg once-daily before randomization
    • +4 more
    • Moscow, Russian Federation
      Moscow Clinical Hospital no.24
    Feb 14, 2022

    COVID-19 Acute Respiratory Distress Syndrome, Hypoxemia Trial in Istanbul (Inhaled Low molecular weight heparin, Standard

    Completed
    • COVID-19 Acute Respiratory Distress Syndrome
    • Hypoxemia
    • Inhaled Low molecular weight heparin
    • Standard Treatment
    • Istanbul, Fatih, Turkey
      Istanbul University Medical Faculty
    Aug 3, 2021

    Arterial Occlusion Trial in Thessaloníki (low molecular weight heparin)

    Completed
    • Arterial Occlusion
    • low molecular weight heparin
    • Thessaloníki, Greece
      1st Cardiology Department, University General Hospital AHEPA
    Jul 28, 2021

    The Clinical Features and Pregnancy Outcomes of CTD Patients

    Recruiting
    • Connective Tissue Diseases
    • Pregnancy Related
    • Jinan, Shandong, China
      Qilu Hospital
    Sep 26, 2022

    Covid19 Trial in Germany (Anticoagulation Agents (Edoxaban and/or high dose LMWH), Low dose Low molecular weight heparin or

    Recruiting
    • Covid19
    • Anticoagulation Agents (Edoxaban and/or high dose LMWH)
    • Low dose Low molecular weight heparin or Placebo
    • Aachen, Germany
    • +9 more
    May 16, 2022

    Venous Thromboembolism, Pulmonary Embolism Trial in Baltimore (VTE prophylaxis with Enoxaparin 30mg BID, VTE prophylaxis with

    Completed
    Has Results
    • Venous Thromboembolism
    • Pulmonary Embolism
    • VTE prophylaxis with Enoxaparin 30mg BID
    • VTE prophylaxis with Aspirin 81mg BID
    • Baltimore, Maryland
      University of Maryland Medical Center
    Jan 3, 2022

    Gather Information About Rivaroxaban in Sweden With Cancer Who

    Active, not recruiting
    • Treatment of Venous Thromboembolism in Cancer Patients
    • Rivaroxaban (Xarelto, BAY59-7939)
    • +3 more
    • Multiple Locations, Many Locations, Sweden
      Swedish registries
    Aug 18, 2022

    Cancer Associated Thrombosis for Rivaroxaban - United States

    Completed
    • Treatment of Venous Thromboembolism in Cancer Patients
    • Prophylaxis of Recurrent Venous Thromboembolism in Cancer Patients
    • Rivaroxaban (Xarelto, BAY59-7939)
    • +2 more
    • Multiple Locations, Connecticut
      Many Locations
    May 18, 2022